Admissions for hepatitis B reactivation in patients receiving immunosuppressive therapy remain unchanged from 1999 to 2014.


Patel A., Yapali S., Lok A.

Hepatology international, cilt.10, ss.139-46, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s12072-015-9659-4
  • Dergi Adı: Hepatology international
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.139-46
  • Anahtar Kelimeler: Hepatitis B virus, Hepatitis, Liver failure, Chemotherapy, Antiviral therapy, PREEMPTIVE LAMIVUDINE, VIRUS REACTIVATION, HBV REACTIVATION, CHEMOTHERAPY, INFECTION, RECOMMENDATIONS, MANAGEMENT, PREVENTION, PSORIASIS, LYMPHOMA
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet